1. Home
  2. NSPR vs TIRX Comparison

NSPR vs TIRX Comparison

Compare NSPR & TIRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • TIRX
  • Stock Information
  • Founded
  • NSPR 2005
  • TIRX 2010
  • Country
  • NSPR United States
  • TIRX China
  • Employees
  • NSPR N/A
  • TIRX N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • TIRX Specialty Insurers
  • Sector
  • NSPR Health Care
  • TIRX Finance
  • Exchange
  • NSPR Nasdaq
  • TIRX Nasdaq
  • Market Cap
  • NSPR 99.7M
  • TIRX 118.4M
  • IPO Year
  • NSPR N/A
  • TIRX 2021
  • Fundamental
  • Price
  • NSPR $2.35
  • TIRX $0.90
  • Analyst Decision
  • NSPR Strong Buy
  • TIRX
  • Analyst Count
  • NSPR 2
  • TIRX 0
  • Target Price
  • NSPR $4.50
  • TIRX N/A
  • AVG Volume (30 Days)
  • NSPR 135.7K
  • TIRX 390.9K
  • Earning Date
  • NSPR 11-11-2025
  • TIRX 08-22-2025
  • Dividend Yield
  • NSPR N/A
  • TIRX N/A
  • EPS Growth
  • NSPR N/A
  • TIRX N/A
  • EPS
  • NSPR N/A
  • TIRX N/A
  • Revenue
  • NSPR $7,066,000.00
  • TIRX N/A
  • Revenue This Year
  • NSPR $7.48
  • TIRX N/A
  • Revenue Next Year
  • NSPR $104.39
  • TIRX N/A
  • P/E Ratio
  • NSPR N/A
  • TIRX N/A
  • Revenue Growth
  • NSPR 7.60
  • TIRX 158.74
  • 52 Week Low
  • NSPR $1.99
  • TIRX $1.00
  • 52 Week High
  • NSPR $3.80
  • TIRX $13.25
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 42.67
  • TIRX 28.28
  • Support Level
  • NSPR $2.30
  • TIRX $1.00
  • Resistance Level
  • NSPR $2.50
  • TIRX $1.11
  • Average True Range (ATR)
  • NSPR 0.09
  • TIRX 0.14
  • MACD
  • NSPR -0.01
  • TIRX -0.15
  • Stochastic Oscillator
  • NSPR 16.98
  • TIRX 5.55

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About TIRX TIAN RUIXIANG Holdings Ltd

Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.

Share on Social Networks: